 Maria Amaya
Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Myeloid, Acute | 14 | 2025 | 620 | 2.340 |
Why?
| | Neoplastic Stem Cells | 5 | 2025 | 398 | 0.970 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 10 | 2025 | 228 | 0.960 |
Why?
| | Amino Acid Transport System ASC | 1 | 2022 | 12 | 0.760 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 8 | 2025 | 1695 | 0.760 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2022 | 48 | 0.740 |
Why?
| | Sulfonamides | 9 | 2025 | 513 | 0.700 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2022 | 141 | 0.690 |
Why?
| | Bendamustine Hydrochloride | 1 | 2020 | 13 | 0.670 |
Why?
| | STAT3 Transcription Factor | 1 | 2022 | 208 | 0.660 |
Why?
| | Isocitrate Dehydrogenase | 2 | 2024 | 60 | 0.620 |
Why?
| | Rituximab | 1 | 2020 | 178 | 0.620 |
Why?
| | Lymphoma, B-Cell | 1 | 2020 | 107 | 0.610 |
Why?
| | Immunoconjugates | 1 | 2020 | 116 | 0.590 |
Why?
| | Azacitidine | 4 | 2023 | 141 | 0.570 |
Why?
| | Signal Transduction | 2 | 2022 | 5096 | 0.520 |
Why?
| | Mi-2 Nucleosome Remodeling and Deacetylase Complex | 2 | 2013 | 26 | 0.500 |
Why?
| | Molecular Targeted Therapy | 1 | 2018 | 414 | 0.470 |
Why?
| | Antibodies, Monoclonal | 2 | 2020 | 1428 | 0.450 |
Why?
| | gamma-Globins | 1 | 2013 | 1 | 0.410 |
Why?
| | Fetal Hemoglobin | 1 | 2013 | 6 | 0.410 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2025 | 121 | 0.410 |
Why?
| | Erythroid Cells | 1 | 2013 | 10 | 0.410 |
Why?
| | Gene Silencing | 2 | 2013 | 195 | 0.400 |
Why?
| | Antineoplastic Agents | 3 | 2025 | 2145 | 0.390 |
Why?
| | Autoantigens | 1 | 2013 | 429 | 0.330 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2024 | 614 | 0.320 |
Why?
| | Hematopoietic Stem Cells | 1 | 2013 | 398 | 0.320 |
Why?
| | Drug Resistance, Neoplasm | 4 | 2025 | 806 | 0.290 |
Why?
| | Oxidative Phosphorylation | 2 | 2024 | 193 | 0.230 |
Why?
| | Transplantation, Haploidentical | 1 | 2024 | 22 | 0.220 |
Why?
| | Leukemia, Myeloid, Chronic-Phase | 1 | 2024 | 1 | 0.220 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2615 | 0.210 |
Why?
| | Cord Blood Stem Cell Transplantation | 1 | 2024 | 99 | 0.210 |
Why?
| | Transplantation Conditioning | 1 | 2024 | 170 | 0.200 |
Why?
| | Tumor Cells, Cultured | 5 | 2022 | 957 | 0.200 |
Why?
| | Mutation | 3 | 2025 | 3964 | 0.200 |
Why?
| | Protein Kinase Inhibitors | 2 | 2025 | 920 | 0.180 |
Why?
| | Prognosis | 4 | 2025 | 4031 | 0.170 |
Why?
| | Lipase | 1 | 2020 | 68 | 0.170 |
Why?
| | Recurrence | 2 | 2023 | 1060 | 0.160 |
Why?
| | Decision Support Systems, Clinical | 1 | 2022 | 219 | 0.150 |
Why?
| | Humans | 26 | 2025 | 137514 | 0.150 |
Why?
| | Repressor Proteins | 2 | 2013 | 425 | 0.150 |
Why?
| | Cell Survival | 1 | 2022 | 1122 | 0.150 |
Why?
| | Calcium | 1 | 2024 | 1233 | 0.150 |
Why?
| | Leukemia | 1 | 2020 | 238 | 0.150 |
Why?
| | Triazines | 1 | 2018 | 43 | 0.140 |
Why?
| | Mitochondria | 1 | 2024 | 947 | 0.140 |
Why?
| | Aminopyridines | 1 | 2018 | 101 | 0.140 |
Why?
| | Thromboplastin | 4 | 2002 | 74 | 0.140 |
Why?
| | Water Pollution, Chemical | 1 | 2016 | 5 | 0.130 |
Why?
| | Treatment Outcome | 5 | 2025 | 10821 | 0.130 |
Why?
| | Water Quality | 1 | 2016 | 32 | 0.130 |
Why?
| | Coal Mining | 1 | 2016 | 23 | 0.130 |
Why?
| | Groundwater | 1 | 2016 | 40 | 0.120 |
Why?
| | Biomarkers, Tumor | 2 | 2024 | 1279 | 0.120 |
Why?
| | Blast Crisis | 2 | 2025 | 33 | 0.110 |
Why?
| | Adult | 8 | 2025 | 37821 | 0.110 |
Why?
| | Nuclear Proteins | 2 | 2024 | 710 | 0.110 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2020 | 1465 | 0.110 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2020 | 1060 | 0.110 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 139 | 0.100 |
Why?
| | Induction Chemotherapy | 2 | 2024 | 74 | 0.100 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2013 | 66 | 0.100 |
Why?
| | Animals | 8 | 2025 | 37011 | 0.090 |
Why?
| | Liver | 1 | 2020 | 1940 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 621 | 0.080 |
Why?
| | Melanoma | 3 | 2002 | 758 | 0.080 |
Why?
| | Platelet Activation | 2 | 2008 | 93 | 0.080 |
Why?
| | Mice | 5 | 2025 | 17843 | 0.080 |
Why?
| | Mice, Transgenic | 2 | 2013 | 2182 | 0.080 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 1 | 2009 | 23 | 0.080 |
Why?
| | Bacterial Typing Techniques | 1 | 2009 | 44 | 0.080 |
Why?
| | Minisatellite Repeats | 1 | 2009 | 42 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2013 | 770 | 0.070 |
Why?
| | Receptors, IgG | 1 | 2008 | 75 | 0.070 |
Why?
| | Antigen-Antibody Complex | 1 | 2008 | 90 | 0.070 |
Why?
| | Neoplasm Proteins | 2 | 2001 | 433 | 0.070 |
Why?
| | Aged | 6 | 2025 | 23798 | 0.070 |
Why?
| | DNA, Bacterial | 1 | 2009 | 336 | 0.070 |
Why?
| | Cell Line, Tumor | 2 | 2025 | 3420 | 0.070 |
Why?
| | Middle Aged | 6 | 2025 | 33355 | 0.060 |
Why?
| | Epigenesis, Genetic | 1 | 2011 | 660 | 0.060 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2009 | 236 | 0.060 |
Why?
| | Models, Molecular | 1 | 2011 | 1586 | 0.060 |
Why?
| | Cells, Cultured | 1 | 2013 | 4206 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2013 | 1979 | 0.060 |
Why?
| | Thrombosis | 1 | 2008 | 368 | 0.060 |
Why?
| | Young Adult | 4 | 2024 | 13243 | 0.050 |
Why?
| | Philadelphia Chromosome | 1 | 2024 | 18 | 0.050 |
Why?
| | GTP Phosphohydrolases | 1 | 2024 | 91 | 0.050 |
Why?
| | Staphylococcal Infections | 1 | 2009 | 402 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2025 | 7593 | 0.050 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2024 | 69 | 0.050 |
Why?
| | Neuraminidase | 1 | 2003 | 25 | 0.050 |
Why?
| | Antigens, CD34 | 1 | 2023 | 88 | 0.050 |
Why?
| | DNA-Binding Proteins | 1 | 2011 | 1507 | 0.050 |
Why?
| | Trypanosoma cruzi | 1 | 2003 | 39 | 0.050 |
Why?
| | Leukocyte Count | 1 | 2024 | 331 | 0.050 |
Why?
| | Neoplasm, Residual | 1 | 2023 | 133 | 0.050 |
Why?
| | CD40 Ligand | 1 | 2002 | 41 | 0.050 |
Why?
| | Tyrosine | 1 | 2003 | 224 | 0.050 |
Why?
| | Graft vs Host Disease | 1 | 2024 | 249 | 0.050 |
Why?
| | CD40 Antigens | 1 | 2002 | 89 | 0.050 |
Why?
| | Stem Cell Transplantation | 1 | 2023 | 177 | 0.050 |
Why?
| | Glycoproteins | 1 | 2003 | 345 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2024 | 15628 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2002 | 254 | 0.040 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2001 | 71 | 0.040 |
Why?
| | Male | 5 | 2025 | 67718 | 0.040 |
Why?
| | Niacinamide | 1 | 2020 | 79 | 0.040 |
Why?
| | Monocytes | 1 | 2002 | 568 | 0.040 |
Why?
| | Female | 5 | 2025 | 73162 | 0.040 |
Why?
| | Blood Platelets | 1 | 2002 | 405 | 0.040 |
Why?
| | Pentoxifylline | 1 | 1998 | 25 | 0.040 |
Why?
| | Hemoglobins | 1 | 2001 | 356 | 0.040 |
Why?
| | Endothelial Growth Factors | 1 | 1998 | 64 | 0.040 |
Why?
| | Free Radical Scavengers | 1 | 1998 | 89 | 0.040 |
Why?
| | Lymphokines | 1 | 1998 | 131 | 0.040 |
Why?
| | Transcriptome | 1 | 2024 | 974 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2024 | 1167 | 0.040 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2001 | 250 | 0.040 |
Why?
| | Neoplasms, Experimental | 1 | 1998 | 176 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2024 | 1770 | 0.030 |
Why?
| | Machine Learning | 1 | 2022 | 496 | 0.030 |
Why?
| | Phenotype | 1 | 2025 | 3205 | 0.030 |
Why?
| | Environmental Restoration and Remediation | 1 | 2016 | 10 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2020 | 682 | 0.030 |
Why?
| | Ohio | 1 | 2016 | 154 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 589 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2755 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2001 | 1402 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2020 | 2482 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2008 | 544 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2011 | 155 | 0.020 |
Why?
| | DNA Primers | 1 | 2011 | 514 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2020 | 4295 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2020 | 5792 | 0.020 |
Why?
| | RNA Interference | 1 | 2011 | 464 | 0.020 |
Why?
| | DNA Fingerprinting | 1 | 2009 | 26 | 0.020 |
Why?
| | Adolescent | 2 | 2024 | 21555 | 0.020 |
Why?
| | Molecular Epidemiology | 1 | 2009 | 67 | 0.020 |
Why?
| | Child | 2 | 2024 | 22037 | 0.020 |
Why?
| | Blotting, Western | 1 | 2011 | 1227 | 0.020 |
Why?
| | Bevacizumab | 1 | 2008 | 137 | 0.020 |
Why?
| | Up-Regulation | 2 | 2002 | 846 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2009 | 502 | 0.020 |
Why?
| | Heparin | 1 | 2008 | 259 | 0.020 |
Why?
| | DNA Methylation | 1 | 2011 | 644 | 0.020 |
Why?
| | Genotype | 1 | 2009 | 1920 | 0.010 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2008 | 807 | 0.010 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2003 | 180 | 0.010 |
Why?
| | Catalysis | 1 | 2003 | 319 | 0.010 |
Why?
| | Solubility | 1 | 2002 | 249 | 0.010 |
Why?
| | Factor VII | 1 | 2001 | 24 | 0.010 |
Why?
| | Chromatography, Affinity | 1 | 2001 | 88 | 0.010 |
Why?
| | Factor VIIa | 1 | 2001 | 41 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2003 | 816 | 0.010 |
Why?
| | Cycloheximide | 1 | 2001 | 55 | 0.010 |
Why?
| | Stimulation, Chemical | 1 | 2001 | 65 | 0.010 |
Why?
| | Factor Xa | 1 | 2001 | 32 | 0.010 |
Why?
| | Dimerization | 1 | 2001 | 198 | 0.010 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2001 | 46 | 0.010 |
Why?
| | Cell Communication | 1 | 2002 | 313 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2001 | 327 | 0.010 |
Why?
| | Kinetics | 1 | 2003 | 1679 | 0.010 |
Why?
| | Antibodies | 1 | 2001 | 414 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2002 | 1357 | 0.010 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 1998 | 79 | 0.010 |
Why?
| | Cell Hypoxia | 1 | 1998 | 227 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2009 | 6059 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2001 | 1185 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 1998 | 659 | 0.010 |
Why?
| | Protein Binding | 1 | 2001 | 2229 | 0.010 |
Why?
| | Infant | 1 | 2009 | 9467 | 0.010 |
Why?
| | Child, Preschool | 1 | 2009 | 11097 | 0.010 |
Why?
| | United States | 1 | 2009 | 14696 | 0.010 |
Why?
| | Rats | 1 | 1998 | 5676 | 0.010 |
Why?
|
|
Amaya's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|